Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › EPHA2 as a therapeutic target for cancer

EPHA2 as a therapeutic target for cancer

US Patent 8591887 · Granted Nov 26, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EphA2 T-cell epitope agonists and uses therefore2023
EPHA2 t-cell epitope agonists and uses therefore2020
EphA2 T-cell epitope agonists and uses therefore2018
EphA2 T-cell epitope agonists and uses therefore2016
Anti-TSG101 antibodies and their uses for treatment of viral infections2014
Methods of inhibiting HIV infectivity2013
Methods of inhibiting viral infection2012
EphA2 T-cell epitopes and uses therefor2012
Therapeutic targeting of escort proteins2011
Anti-TSG101 antibodies and their uses for treatment of viral infections2011
EphA2 as a therapeutic target for cancer2010
EphA2 as a therapeutic target for cancer2010